Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 in Response

Visual Abstract. Ensovibep for Adults Hospitalized With COVID-19. Novel therapies for SARS-CoV-2 infection have been a focus of research, and many promising compounds have emerged. This multinational clinical trial compared one such compound-ensovibep, a designed ankyrin repeat protein-versus standard of care to determine whether it improved outcomes among patients hospitalized with COVID-19.

Automated summary

This is a multinational clinical trial that compared ensovibep, a designed ankyrin repeat protein, with standard of care to evaluate its effectiveness in improving outcomes of hospitalized COVID-19 patients.